Aviva Gross

Aviva Gross

UNVERIFIED PROFILE

Are you Aviva Gross?   Register this Author

Register author
Aviva Gross

Aviva Gross

Publications by authors named "Aviva Gross"

Are you Aviva Gross?   Register this Author

8Publications

125Reads

13Profile Views

Pharmacokinetics and safety of single and multiple doses of rasagiline in healthy Japanese and caucasian subjects.

Basic Clin Pharmacol Toxicol 2019 Mar 21;124(3):273-284. Epub 2018 Oct 21.

Teva Pharmaceuticals Ltd., Netanya, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcpt.13131DOI Listing
March 2019

TV-1380 attenuates cocaine-induced changes in cardiodynamic parameters in monkeys and reduces the formation of cocaethylene.

Drug Alcohol Depend 2018 07 26;188:295-303. Epub 2018 Mar 26.

Non-Clinical Development, Teva Pharmaceutical Ltd, Netanya, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2018.01.033DOI Listing
July 2018

Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase.

Eur J Pharmacol 2012 May 23;683(1-3):226-30. Epub 2012 Mar 23.

Dept of Molecular Pharmacology, Rappaport Faculty of Medicine, Technion, POB 9649, Haifa 31096, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2012.03.026DOI Listing
May 2012

A possible new role for fish retinal serotonin-N-acetyltransferase-1 (AANAT1): Dopamine metabolism.

Brain Res 2006 Feb 19;1073-1074:220-8. Epub 2006 Jan 19.

Department of Zoology, George S. Wise Faculty of Life Sciences, Tel Aviv University, 69978 Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brainres.2005.12.028DOI Listing
February 2006

Rasagiline enhances L-DOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea-pig.

Neuropharmacology 2004 Jul;47(1):72-80

Pharmacology Department, Rappaport Family Faculty of Medicine, Technion, P.O. Box 9649, 31096 Haifa, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuropharm.2004.02.016DOI Listing
July 2004

A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease.

Prog Neuropsychopharmacol Biol Psychiatry 2003 Jun;27(4):555-61

Department of Pharmacology, Hebrew University Hadassah School of Medicine, Ein Kerem, 91120, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0278-5846(03)00053-8DOI Listing
June 2003